2024    2023    2022    2021    2020    2019    2018    2017    2016   

2017

Articles

141 - 

Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing.

Cedric Pastoret, Roch Houot, Francisco Llamas-Gutierrez, Marie-Laure Boulland, Tony Marchand et al.

Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing. Leukemia & lymphoma, 2017, 58 (4), pp.1008-1012.

DOI : https://doi.org/10.1080/10428194.2016.1225208

Pubmed : 27659839

 

142 - 

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension

Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, Stefania Paolillo, Francisco Alpendurada et al.

Journal of Hypertension, 2017, 35 (9), pp.1727-1741.

DOI : https://doi.org/10.1097/HJH.0000000000001396

Pubmed : 28767484

 

143 - 

Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients

Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, Stefania Paolillo, Francisco Alpendurada et al.

European Heart Journal - Cardiovascular Imaging, 2017, 18 (9), pp.945-960.

DOI : https://doi.org/10.1093/ehjci/jex094

Pubmed : 28977550

 

144 - 

Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose

Antoine Petitcollin, C. Boglione-Kerrien, C. Tron, S. Nimubona, S. Lalanne et al.

Antimicrobial Agents and Chemotherapy, 2017, 61 (11), pp.e01166-17.

DOI : https://doi.org/10.1128/AAC.01166-17

Pubmed : 28848009

 

145 - 

Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study

Benoit Peyronnet, Evelyne Castel-Lacanal, Mathieu Roumiguié, Lucie Even, Philippe Marque et al.

Neurourology and Urodynamics, 2017, 36 (3), pp.734-739.

DOI : https://doi.org/10.1002/nau.23009

Pubmed : 27037973

 

146 - 

Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis

Raphael Philippart, Anne Brunet-Bernard, Nicolas Clementy, Thierry Bourguignon, Alain Mirza et al.

Thrombosis and Haemostasis, 2017, 115 (05), pp.1056-1063.

DOI : https://doi.org/10.1160/TH16-01-0007

Pubmed : 26843425

 

147 - 

Clinical predictors of challenging atrioventricular node ablation procedure for rate control in patients with atrial fibrillation

B. Polin, N. Behar, V. Galand, V. Auffret, A. Behaghel et al.

International Journal of Cardiology, 2017, 245, pp.168-173.

DOI : https://doi.org/10.1016/j.ijcard.2017.05.009

Pubmed : 28874289

 

148 - 

Impact of Anticoagulant and Antiplatelet Drugs on Perioperative Outcomes of Robotic-assisted Partial Nephrectomy

Benjamin Pradère, Benoit Peyronnet, Thomas Seisen, Zineddine Khene, Marina Ruggiero et al.

Urology, 2017, 99, pp.118-122.

DOI : https://doi.org/10.1016/j.urology.2016.09.009

Pubmed : 27669654

 

149 - 

Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients

Véronique Quillien, Audrey Lavenu, François Ducray, David Meyronet, Olivier Chinot et al.

Cancer Biomarkers, 2017, 20 (4), pp.435-441.

DOI : https://doi.org/10.3233/CBM-170191

Pubmed : 28800313

 

150 - 

Pancreaticobiliary Maljunctions in European Patients with Bile Duct Cysts: Results of the Multicenter Study of the French Surgical Association (AFC)

Emilia Ragot, Jean-Yves Mabrut, Mehdi Ouaissi, Alain Sauvanet, Safi Dokmak et al.

World Journal of Surgery, 2017, 41 (2), pp.538-545.

DOI : https://doi.org/10.1007/s00268-016-3684-x

Pubmed : 27620132